259 related articles for article (PubMed ID: 16809779)
1. Cyclin D1 determines mitochondrial function in vivo.
Sakamaki T; Casimiro MC; Ju X; Quong AA; Katiyar S; Liu M; Jiao X; Li A; Zhang X; Lu Y; Wang C; Byers S; Nicholson R; Link T; Shemluck M; Yang J; Fricke ST; Novikoff PM; Papanikolaou A; Arnold A; Albanese C; Pestell R
Mol Cell Biol; 2006 Jul; 26(14):5449-69. PubMed ID: 16809779
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function.
Wang C; Li Z; Lu Y; Du R; Katiyar S; Yang J; Fu M; Leader JE; Quong A; Novikoff PM; Pestell RG
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11567-72. PubMed ID: 16864783
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 determines estrogen signaling in the mammary gland in vivo.
Casimiro MC; Wang C; Li Z; Di Sante G; Willmart NE; Addya S; Chen L; Liu Y; Lisanti MP; Pestell RG
Mol Endocrinol; 2013 Sep; 27(9):1415-28. PubMed ID: 23864650
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
5. Concurrent deregulation of gelsolin and cyclin D1 in the majority of human and rodent breast cancers.
Dong Y; Asch HL; Medina D; Ip C; Ip M; Guzman R; Asch BB
Int J Cancer; 1999 Jun; 81(6):930-8. PubMed ID: 10362141
[TBL] [Abstract][Full Text] [Related]
6. Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis.
Casimiro MC; Di Sante G; Crosariol M; Loro E; Dampier W; Ertel A; Yu Z; Saria EA; Papanikolaou A; Li Z; Wang C; Addya S; Lisanti MP; Fortina P; Cardiff RD; Tozeren A; Knudsen ES; Arnold A; Pestell RG
Oncotarget; 2015 Apr; 6(11):8525-38. PubMed ID: 25940700
[TBL] [Abstract][Full Text] [Related]
7. p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells.
Balasenthil S; Sahin AA; Barnes CJ; Wang RA; Pestell RG; Vadlamudi RK; Kumar R
J Biol Chem; 2004 Jan; 279(2):1422-8. PubMed ID: 14530270
[TBL] [Abstract][Full Text] [Related]
8. Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors.
Ling H; Sylvestre JR; Jolicoeur P
Oncogene; 2010 Aug; 29(32):4543-54. PubMed ID: 20562911
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 induction of cellular migration requires p27(KIP1).
Li Z; Jiao X; Wang C; Ju X; Lu Y; Yuan L; Lisanti MP; Katiyar S; Pestell RG
Cancer Res; 2006 Oct; 66(20):9986-94. PubMed ID: 17047061
[TBL] [Abstract][Full Text] [Related]
10. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E.
Bowe DB; Kenney NJ; Adereth Y; Maroulakou IG
Oncogene; 2002 Jan; 21(2):291-8. PubMed ID: 11803472
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis.
Landis MW; Pawlyk BS; Li T; Sicinski P; Hinds PW
Cancer Cell; 2006 Jan; 9(1):13-22. PubMed ID: 16413468
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
Jones RA; Campbell CI; Petrik JJ; Moorehead RA
Mol Cancer Res; 2008 May; 6(5):819-28. PubMed ID: 18505926
[TBL] [Abstract][Full Text] [Related]
14. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.
Wang TC; Cardiff RD; Zukerberg L; Lees E; Arnold A; Schmidt EV
Nature; 1994 Jun; 369(6482):669-71. PubMed ID: 8208295
[TBL] [Abstract][Full Text] [Related]
15. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
16. Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis.
Lin DI; Lessie MD; Gladden AB; Bassing CH; Wagner KU; Diehl JA
Oncogene; 2008 Feb; 27(9):1231-42. PubMed ID: 17724472
[TBL] [Abstract][Full Text] [Related]
17. Forced expression of cyclin D1 does not compensate for Id2 deficiency in the mammary gland.
Mori S; Inoshima K; Shima Y; Schmidt EV; Yokota Y
FEBS Lett; 2003 Sep; 551(1-3):123-7. PubMed ID: 12965216
[TBL] [Abstract][Full Text] [Related]
18. Endogenous Cyclin D1 Promotes the Rate of Onset and Magnitude of Mitogenic Signaling via Akt1 Ser473 Phosphorylation.
Chen K; Jiao X; Di Rocco A; Shen D; Xu S; Ertel A; Yu Z; Di Sante G; Wang M; Li Z; Pestell TG; Casimiro MC; Skordalakes E; Achilefu S; Pestell RG
Cell Rep; 2020 Sep; 32(11):108151. PubMed ID: 32937140
[TBL] [Abstract][Full Text] [Related]
19. IGF-2 is a mediator of prolactin-induced morphogenesis in the breast.
Brisken C; Ayyannan A; Nguyen C; Heineman A; Reinhardt F; Tan J; Dey SK; Dotto GP; Weinberg RA
Dev Cell; 2002 Dec; 3(6):877-87. PubMed ID: 12479812
[TBL] [Abstract][Full Text] [Related]
20. Requirement for CDK4 kinase function in breast cancer.
Yu Q; Sicinska E; Geng Y; Ahnström M; Zagozdzon A; Kong Y; Gardner H; Kiyokawa H; Harris LN; Stål O; Sicinski P
Cancer Cell; 2006 Jan; 9(1):23-32. PubMed ID: 16413469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
